Showing results (71-80 of 152) with videos related to
Sort By:
Pageof 16
Cancer|July 9, 2026
Circulating tumor DNA in early breast cancer: Evidence, challenges, next stepsSerena Di Cosimo, Valentina Appierto, Carolina Reduzzi, et al.Journal of the National Cancer Institute|April 4, 2026
The benefit of adjuvant pertuzumab and trastuzumab according to estrogen receptor and HER2 expression: a Sub-analysis of the APHINITY trialElisa Agostinetto, Gabriella Gentile, Faye Samy, et al.Clinical Breast Cancer|May 19, 2018
Hypofractionated Whole-Breast Irradiation With or Without Boost in Elderly Patients: Clinical Evaluation of an Italian ExperienceMaria Carmen De Santis, Francesca Bonfantini, Francesca Di Salvo, et al.Clinical Breast Cancer|September 30, 2017
Trastuzumab and Hypofractionated Whole Breast Radiotherapy: A Victorious Combination?Maria Carmen De Santis, Francesca Bonfantini, Francesca Di Salvo, et al.Journal of the National Cancer Institute|August 5, 2020
Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine TherapyMaria Alice Franzoi, Daniel Eiger, Lieveke Ameye, et al.Breast (Edinburgh, Scotland)|January 7, 2026
HER2/CEP17 ratio is associated with pCR after HER2-directed neoadjuvant treatment in the phase III NeoALTTO trialChristian F Singer, Franz Koenig, Stephanie Kacerovsky-Strobl, et al.Breast Cancer Research : BCR|October 28, 2020
Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trialSerena Di Cosimo, Luca Porcu, Dominique Agbor-Tarh, et al.Oncotarget|September 4, 2015
Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltrationTiziana Triulzi, Loris De Cecco, Marco Sandri, et al.Breast (Edinburgh, Scotland)|May 27, 2025
Advancing breast cancer therapy in the era of molecular diagnosticsMaria Grazia Carnevale, Riccardo Ray Colciago, Maria Carmen De Santis, et al.Cancers|November 14, 2019
Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity before and after Neoadjuvant ChemotherapySerena Di Cosimo, Valentina Appierto, Marco Silvestri, et al.Pageof 16